Lenvima 18 mg Daily Dose Capsules (Lenvatinib)

Lenvima 18 mg Daily Dose Capsules (Lenvatinib)

Description :

Minimum Order Quantity 1 carton
Packaging Size 1 carton contains five 10 mg capsules and ten 4 mg capsules
Brand Name Lenvima
Active Ingredient Lenvatinib
Strength 18 mg
Dosage form ; Route of administration Capsule ; Oral
Manufacture by Eisai

Non Prescription

Usage As directed by the physician
Additional Information Pay Mode Terms: T/T (Bank Transfer)

Introduction: Lenvima 18 mg capsule is an oral receptor tyrosine kinase inhibitor used in the treatment of thyroid cancer.

Mode of action: It acts by blocking the oxygen and nutrient supply to cancer cells due to which they stop growing.

Dosage: The doctor will advise the dose and duration of the dosage form.

Special Precautions: Investigate blood tests to check for liver, kidney and level of thyroid stimulating hormones.

Side Effects: The most common side effects of this medicine include tiredness, joint pain, muscle pain, nausea and vomiting.

Send Enquiry